MeTeOR2 is a randomised controlled trial comparing meniscal allograft transplant surgery to personalised knee therapy in people with pain and/or functional limitations post partial meniscectomy. The study aims to identify if one treatment is superior to another for pain and self-report functioning.
If you are interested in the study and consent to participate, you will have a 50% chance of being randomised into one of the two groups. The first group will receive a meniscal allograft transplant surgery. This surgery involves the implantation of a meniscus which has been procured from a deceased person into a meniscal deficient knee. The second group will receive personalised knee therapy. This will involve an assessment of your knee and functioning, and the prescription of a treatment plan tailored to your needs based on this assessment.
Participants in both groups will be asked to complete a series of questionnaires at baseline and 3-, 6-, 12-, 18-, and 24-months following randomisation. The primary outcome will be collected at 24-months after randomisation.
You may be eligible to participate in this study if you:
If you are interested in assisting with this important and exciting area of research, please contact the study facilitator: firstname.lastname@example.org